Vijayabhaskar Veeravalli

Dr. Vijayabhaskar Veeravalli


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LTLukáš Tenora
Lukáš Tenora
JAJesse Alt
Jesse Alt
RDRanjeet P. Dash
Ranjeet P. Dash
AGAlexandra J. Gadiano
Alexandra J. Gadiano
KNKateřina Novotná
Kateřina Novotná
BSBarbara S. Slusher
Barbara S. Slusher

9 September 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EPEva Prchalová
Eva Prchalová
NHNiyada Hin
Niyada Hin
ATAjit G. Thomas
Ajit G. Thomas
VVVijayabhaskar Veeravalli
Vijayabhaskar Veeravalli
JNJustin Ng
Justin Ng
TTTakashi Tsukamoto
Takashi Tsukamoto

1 February 2020 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
KLKathryn M. Lemberg
Kathryn M. Lemberg
LZLiang Zhao
Liang Zhao
YWYing Wu
Ying Wu
VVVijayabhaskar Veeravalli
Vijayabhaskar Veeravalli
JAJesse Alt
Jesse Alt
BSBarbara S. Slusher
Barbara S. Slusher
The carbon and nitrogen components of glutamine are used for multiple biosynthetic processes by tumors. Glutamine metabolism and the therapeutic potential of glutamine antagonists (GA), however, are incompletely understood in malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma observed in patients with neurofibromatosis type I. We investigated glutamine dependence of MPNST using JHU395, a novel orally bioavailable GA prodrug designed to circulate inert in plasma, but permeate and release active GA within target tissues. Human MPNST cells, compared with Schwann cells derived from healthy peripheral nerve, were selectively susceptible to both glutamine deprivation and GA dose-dependent growth inhibition. In vivo, orally administered JHU395 delivered active GA to tumors with over 2-fold higher tumor-to-plasma exposure, and significantly inhibited tumor growth in a murine flank MPNST model without observed toxicity. Global metabolomics studies and stable isotope–labeled flux analyses in tumors identified multiple glutamine-dependent metabolites affected, including prominent effects on purine synthesis. These data demonstrate that glutamine antagonism is a potential antitumor strategy for MPNST.

1 May 2013 in Journal of Chromatography B
Verified
Journal Article
Closed access
VVVijayabhaskar Veeravalli
Vijayabhaskar Veeravalli
AMAnil Middha
Anil Middha
STSudhir Tiwari
Sudhir Tiwari
SSSavithiri Shivakumar
Savithiri Shivakumar

10 September 2019 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
RDRanjeet P. Dash
Ranjeet P. Dash
TTTomáš Tichý
Tomáš Tichý
VVVijayabhaskar Veeravalli
Vijayabhaskar Veeravalli
JLJenny Lam
Jenny Lam
JAJesse Alt
Jesse Alt
RRRana Rais
Rana Rais

5 February 2018 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ASAmarinder Singh
Amarinder Singh
TTThanusha Thatikonda
Thanusha Thatikonda
AKAmit Kumar
Amit Kumar
PWPriya Wazir
Priya Wazir
VVVijayabhaskar Veeravalli
Vijayabhaskar Veeravalli
RVRam Vishwakarma
Ram Vishwakarma